Skip to content
Screener

Rapport Therapeutics, Inc. RAPP Q1 2025 earnings

Reported May 8, 2025 · Before market open

Revenue-
EPS-$0.68Beat by $0.09
EPS estimate-$0.77

Next report

Nov 5, 2026 (in 3 months)
EPS estimate-$1.21

Financials

Q1 2025

Income statement

See full
Revenue-—
Operating income-$27.1M-58.6%
Net income-$24.1M-6.1%
EPS (diluted)-$0.68+93.9%

Balance sheet

See full
Cash & equivalents$57.6M-22.4%
Total debt$7.8M—
Total equity$285.8M+821%
Total assets$302.1M—

Cash flow

See full
Operating cash flow-$20.2M-14.9%
CapEx$291.0K-72.9%
Free cash flow-$20.5M-9.9%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$366.06M—
Enterprise value$316.3M—

Returns & leverage

See full
Debt / equity0×—
Current ratio31×—

FAQ

When did Rapport Therapeutics, Inc. report Q1 2025 earnings?
Rapport Therapeutics, Inc. (RAPP) reported Q1 2025 earnings on May 8, 2025 before market open.
What were Rapport Therapeutics, Inc.'s Q1 2025 revenue and EPS?
Rapport Therapeutics, Inc. reported revenue of - and eps of $-0.68 for Q1 2025.
Did Rapport Therapeutics, Inc. beat estimates in Q1 2025?
EPS beat the consensus estimate of $-0.77 by $0.09.
Where can I find Rapport Therapeutics, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-066376) and the 10-Q periodic report (0000950170-25-066393) directly on SEC EDGAR. The filing index links above go to sec.gov.